Synexa Life Sciences Ltd

Synexa Life Sciences Ltd, based in London, UK, is a small, active company founded twelve years ago in 2012. With eighteen employees and £3,374,119 in assets, it operates from a virtual address, a common characteristic of smaller businesses. Two directors manage the company, and, interestingly, no owners are currently listed – a situation often seen in privately held firms. The company regularly imports miscellaneous chemical products, with recent activity recorded as of July 2024.

The company's website reveals a more detailed picture: Synexa Group specializes in biomarker and bioanalytical services, supporting clinical trials and translational studies across various industries, including autoimmune, oncology, vaccines, and biosimilars. It operates five global laboratory locations, offering services like flow cytometry, proteomics, and genomics. The website emphasizes a team of over 200 staff and a focus on “bridging the gap between science and life.”

Financially, Synexa Life Sciences Ltd shows a mixed picture. While cash bank on hand increased significantly by 260% to £120,000, net assets increased by 55% to £480,000. However, creditors also increased by 130%, reaching £240,000, and trade debtors decreased by a whopping 100% to zero. Average number of employees increased by 44% to 26. The company’s small size—meeting two of three criteria for being considered small—helps it remain flexible, but the increase in creditors suggests it may be relying more on short-term financing. The lack of an auditor mentioned likely means the figures are unaudited. It seems like Synexa Life Sciences Ltd is growing, but it's also managing increased financial pressures.

Registered in England/Wales under the registration number 08249730, with a registered address at W1T 4RN, United Kingdom, London, 1st Floor Arthur Stanley House, 40-50 Tottenham Street.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.